PATZ1 interacts with p53 and regulates expression of p53-target genes enhancing apoptosis or cell survival based on the cellular context

Cell Death and Disease

Volumn 4, Issue 12, 2013, Pages

  Valentino, T ^a,b   Palmieri, D ^c   Vitiello, M ^a,b   Pierantoni, G M ^a,b   Fusco, A ^a,b   Fedele, M ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

apoptosis; cell survival; gene regulation; oncogene; tumour suppressor

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FLUOROURACIL; MEMBRANE PROTEIN; PROTEIN BAX; PROTEIN MDM2; PROTEIN P53; PROTEIN PATZ1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL STRAIN HEK293; CELL SURVIVAL; CELL VIABILITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; DOWN REGULATION; EMBRYO; EMBRYO CELL; FIBROBLAST; INHIBITION KINETICS; MOUSE; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAJI CELL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STABLE TRANSFECTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MDM2; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84891822439     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.500     Document Type: Article

References (38)

1. Fedele M, Benvenuto G, Pero R, Majello B, Battista S, Lembo F et al. A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J Biol Chem 2000; 275: 7894-7901
2. Kobayashi A, Yamagiwa H, Hoshino H, Muto A, Sato K, Morita M et al. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol Cell Biol 2000; 20: 1733-1746
3. Mastrangelo T, Modena P, Tornielli S, Bullrich F, Testi MA, Mezzelani A et al. A novel zinc finger gene is fused to EWS in small round cell tumour. Oncogene 2000; 19: 3799-37804
4. Costoya JA. Functional analysis of the role of POK transcriptional repressors. Brief Funct Genomic Proteomic 2007; 6: 8-18
5. Kelly KF, Daniel JM. POZ for effect-POZ-ZF transcription factors in cancer and development. Trends Cell Biol 2006; 16: 578-587
6. Jeon BN, Choi WI, Yu MY, Yoon AR, Kim MH, Yun CO et al. ZBTB2, a novel master regulator of the p53 pathway. J Biol Chem 2009; 284: 17935-17946
7. Jeon BN, Kim MK, Choi WI, Koh DI, Hong SY, Kim KS et al. KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A. Cancer Res 2012; 72: 1137-1148
8. Cho JH, Kim MJ, Kim K, Jand Kim Jr. POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits endothelial cell senescence through a p53 dependent pathway. Cell Death Differ 2012; 19: 703-712
9. Morii E, Oboki K, Kataoka TR, Igarashi K, Kitamura Y. Interaction and cooperation of mi transcription factor (MITF) and myc-Associated zinc-finger protein-related factor (MAZR) for trascription of mouse mast cell protease 6 gene. J Biol Chem 2002; 277: 8566-8571
10. Pero R, Lembo F, Palmieri EA, Vitiello C, Fedele M, Fusco A et al. PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription. J Biol Chem 2002; 277: 3280-3285
11. Bilic I, Koesters C, Unger B, Sekimata M, Hertweck A, Maschek R et al. Negative regulation of CD8 expression via Cd8 enhancer-mediated recruitment of the zinc finger protein MAZR. Nat Immunol 2006; 7: 392-400
12. Sakaguchi S, Hombauer M, Bilic I, Naoe Y, Schebesta A, Taniuchi I et al. The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes. Nat Immunol 2010; 11: 442-448
13. Pero R, Palmieri D, Angrisano T, Valentino T, Federico A, Franco R et al. POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. J Biol Chem 2012; 287: 18308-18317
14. Burrow AA, Williams LE, Pierce LC, Wang YH. Over half of breakpoints in gene pairs involved in cancer-specific recurrent translocations are mapped to human chromosomal fragile sites. BMC Genomics 2009; 10: 59
15. Valentino T, Palmieri D, Vitiello M, Simeone A, Palma G, Arra C et al. Embryonic defects and growth alteration in mice with homozygous disruption of the Patz1 gene. J Cell Physiol 2012; 228: 646-653
16. Tian X, Sun D, Zhang Y, Zhao S, Xiong H, Fang J. Zinc finger protein 278, a potential oncogene in human colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 2008; 40: 289-296
17. Fedele M, Franco R, Salvatore G, Paronetto MP, Barbagallo F, Pero R et al. PATZ1 gene has a critical role in the spermatogenesis and testicular tumours. J Pathol 2008; 215: 39-47
18. Yang WL, Ravatn R, Kudoh K, Alabanza L, Chin KV. Interaction of the regulatory subunit of the cAMP-dependent protein kinase with PATZ1 (ZNF278). Biochem Biophys Res Commun 2010; 391: 1318-1323
19. Tritz R, Mueller BM, Hickey MJ, Lin AH, Gomez GG, Hadwiger P et al. siRNA down-regulation of the PATZ1 gene in human glioma cells increases their sensitivity to apoptotic stimuli. Cancer Ther 2008; 6: 865-876
20. Zilfou JT, Lowe SW. Tumour suppressive functions of p53. Cold Spring Harb Perspect Biol 2009; 1: A001883
21. Pierantoni GM, Rinaldo C, Esposito F, Mottolese M, Soddu S, Fusco A. High Mobility Group. A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity. Cell Death Differ 2006; 13: 1554-1563
22. Menendez D, Inga A, Resnick MA. The expanding universe of p53 targets. Nat Rev Cancer 2009; 9: 724-737
23. Fedele M, Pierantoni GM, Pallante P, Fusco A. High mobility group. A-interacting proteins in cancer: Focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ. J Nucl Acids Inv 2012; 3: E1
24. Jegga AG, Sherwood SP, Carman JW, Pinski AT, Phillips JL, Pestian JP et al. Detection and visualization of compositionally similar cis-regulatory element clusters in orthologous and coordinately controlled genes. Genome Res 2002; 12: 1408-1417
25. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3: 330-338
26. Malaguarnera R, Vella V, Vigneri R, Frasca F. p53 family proteins in thyroid cancer. Endocr Relat Cancer 2007; 14: 43-60
27. Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F et al. Detection of high mobility group. I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res 1998; 58: 4193-4198
28. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011; 476: 298-303
29. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43: 830-837
30. Lohr JG, Stojanov P, Lawrence MS, Auclair D, Chapuy B, Sougnez C et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879-3884
31. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068
32. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615
33. Monti S, Chapuy B, Takeyama K, Rodig SJ, Hao Y, Yeda KT et al. Integrative analysis reveals an outcome-Associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma. Cancer Cell 2012; 22: 359-372
34. Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432: 635-639
35. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-Type p53. Science 1990; 249: 912-915
36. Fedele M, Visone R, De Martino I, Troncone G, Palmieri D, Battista S et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 2006; 9: 459-471
37. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 2001; 15: 2069-2082
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408